Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • Thomas Meyer - , Charité – Universitätsmedizin Berlin, Ambulanzpartner Soziotechnologie APST GmbH, Berlin, Germany. (Author)
  • Dagmar Kettemann - , Berlin Institute of Health at Charité (Author)
  • André Maier - , Berlin Institute of Health at Charité (Author)
  • Torsten Grehl - , Alfried Krupp Krankenhaus (Author)
  • Ute Weyen - , BG University Hospital Bergmannsheil Bochum (Author)
  • Julian Grosskreutz - , Jena University Hospital (Author)
  • Robert Steinbach - , Jena University Hospital (Author)
  • Jenny Norden - , Berlin Institute of Health at Charité (Author)
  • Annette George - , Berlin Institute of Health at Charité (Author)
  • Andreas Hermann - , German Center for Neurodegenerative Diseases (DZNE) - Partner Site Rostock/Greifswald (Author)
  • René Günther - , Department of Neurology, German Center for Neurodegenerative Diseases, Dresden site (Partner: DZNE of the Helmholtz Association) (Author)
  • Susanne Petri - , Hannover Medical School (MHH) (Author)
  • Olivia Schreiber-Katz - , Hannover Medical School (MHH) (Author)
  • Johannes Dorst - , Ulm University Medical Center (Author)
  • Albert C Ludolph - , Ulm University Medical Center (Author)
  • Bertram Walter - , Berlin Institute of Health at Charité (Author)
  • Christoph Münch - , Ambulanzpartner Soziotechnologie APST GmbH, Berlin, Germany. (Author)
  • Susanne Spittel - , Ambulanzpartner Soziotechnologie APST GmbH, Berlin, Germany. (Author)

Details

Original languageEnglish
Pages (from-to)783-785
Number of pages3
JournalJournal of Neurology, Neurosurgery and Psychiatry
Volume91
Issue number7
Publication statusPublished - Jul 2020
Peer-reviewedYes

External IDs

PubMedCentral PMC7361015
Scopus 85083794932

Keywords

Keywords

  • Aged, Amyotrophic Lateral Sclerosis/drug therapy, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Neuroprotective Agents/therapeutic use, Prospective Studies, Riluzole/therapeutic use, Treatment Outcome